Table 1.
Baseline characteristics of COVID-19 patients (n = 47).
| Age, years - median, IQR | 63 (29–79) |
| Sex - n (%) | |
| Male | 38 (81) |
| Female | 11 (19) |
| BMI, kg/m2 - median, IQR | 28.8 (24.4–48.4) |
| Mechanically ventilated - n (%) | 47 (100) |
| APACHE IV score - median, IQR | 63 (15–108) |
| SAPS II score - median, IQR | 42 (17–70) |
| CCI score - median, IQR | 3.6 (0−12) |
| Length of ICU admission at time of the study, days - median, IQR | 8 (1–25) |
| Total length of ICU stay, days - median, IQR | 18 (7–47) |
| Anticoagulant - n (%) | |
| Prophylactic LMWH | 41 (87%) |
| Therapeutic LMWH | 2 (4%) |
| Unfractionated heparin | 4 (9%) |
| CT - n (%) | |
| CT | 17 (36%) |
| No CT | 30 (64%) |
| Thromboembolic complication - n (%) | |
| Thromboembolic complication | 10 (21%) |
| No thromboembolic complication | 37 (79%) |
| ICU outcome - n (%) | |
| Alive to ward and home | 40 (85%) |
| Death | 7 (15%) |
Abbreviations: BMI = Body Mass Index; APACHE IV = Acute Physiology And Chronic Health Evaluation; SAPS = Simplified Acute Physiology Score; CCI = Charlson Comorbidity Index; LMWH = low molecular weight heparin; ICU = Intensive Care Unit; CT = Computed Tomography.